EURO EUS MEETING
Year : 2014 | Volume
: 3 | Issue : 5 | Page : 17-
To evaluate the role of novel fully covered self-expanding metal stent for endoscopic drainage of infected pancreatic pseudocyst
P Rai1, S Munjal2, M Sharma2, M Sharma3,
1 Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
2 Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
3 Jaswant Rai Super Speciality Hospital, Meerut, Uttar Pradesh, India
|How to cite this article:|
Rai P, Munjal S, Sharma M, Sharma M. To evaluate the role of novel fully covered self-expanding metal stent for endoscopic drainage of infected pancreatic pseudocyst.Endosc Ultrasound 2014;3:17-17
|How to cite this URL:|
Rai P, Munjal S, Sharma M, Sharma M. To evaluate the role of novel fully covered self-expanding metal stent for endoscopic drainage of infected pancreatic pseudocyst. Endosc Ultrasound [serial online] 2014 [cited 2020 Sep 19 ];3:17-17
Available from: http://www.eusjournal.com/text.asp?2014/3/5/17/129530
Introduction: Endoscopic ultrasonography-guided transgastric drainage of pancreatic pseudocyst (PPC) is the mainstay of treatment. Drainage can be achieved either by plastic stents or fully covered self-expandable metal stent (FCSEMS). Plastic stents have small lumen diameter, which may limit drainage and may necessitate re-intervention. FCSEMS are easier to deploy and preclude the need to place multiple plastic stents.
Objective: To evaluate the role of novel FCSEMS for endoscopic drainage of infected PPC.
Methods: Patients: 10 patients with single symptomatic pseudocyst in proximity to the stomach or duodenum and fever were treated. Pseudocyst drainage was done per protocol. Repeat computed tomography scan after 72 h. Nasocystic drain removed after 3-5 days. Patients were followed-up at every 2 week interval. Stent was removed after complete disappearance of pseudocyst confirmed on imaging. Early (7 days) and late (>7 days) complications were noted and managed accordingly.
Results: Technical success and clinical success achieved in all. Early complication: 1/10 (pneumoperitoneum). No late complications observed. Stent were removed without complication after 6-7 week follow-up period ranges from 6 to 8 months.
Conclusion: Use of FCSEMS for pseudocyst drainage is technically feasible and safe.
Status of the presenting author: Chief resident
The authors declare: No significant relationship.